A Bayesian meta-analysis comparing AngioJet thrombectomy to percutaneous coronary intervention alone in acute
Cindy L Grines1, Teresa R Nelson, Robert D Safian
1Division of Cardiology, William Beaumont Hospital, Royal Oak, MI 48073, USA. cgrines@beaumont.edu
Insights
AngioJet thrombectomy combined with PCI shows similar outcomes to PCI alone for acute myocardial infarction (AMI) patients. This suggests AngioJet may mitigate risks associated with thrombus in heart attack patients.
Area of Science:
- Cardiology
- Interventional Cardiology
- Acute Myocardial Infarction Treatment
Background:
- Percutaneous coronary intervention (PCI) is standard for acute myocardial infarction (AMI) revascularization.
- The adjunctive benefit of thrombectomy with PCI remains debated.
Purpose of the Study:
- To compare outcomes of AngioJet thrombectomy plus PCI versus PCI alone in AMI patients.
- To evaluate short-term mortality, major adverse cardiac events (MACE), and final TIMI 3 flow.
Main Methods:
- Bayesian meta-analysis of AMI studies (1999-2007).
- Compared AngioJet + PCI (1,018 patients) with PCI alone (24,076 patients).
- Analyzed odds ratios for mortality, MACE, and TIMI 3 flow.
Main Results:
- AngioJet group had higher risk profiles (larger thrombus, longer symptoms).
- No significant differences in short-term mortality (OR 0.98), MACE (OR 1.25), or TIMI 3 flow (OR 1.12).
- Outcomes were similar despite higher-risk AngioJet cohort.
Conclusions:
- AngioJet thrombectomy with PCI yields similar clinical and angiographic results to PCI alone in lower-risk AMI patients.
- May reduce risks associated with thrombus in infarct-related lesions.
Objective:
The purpose of this meta-analysis was to compare outcomes for AngioJet thrombectomy versus percutaneous coronary intervention (PCI) without thrombectomy in acute myocardial infarction (AMI) patients.
Background:
PCI is the preferred treatment for revascularizing the infarct-related artery in patients with AMI. There is controversy about the benefits of thrombectomy as an adjunct to PCI.
Methods:
AMI studies published between January 1, 1999, and March 1, 2007, were used to compare AngioJet thrombectomy plus PCI to PCI alone. Bayesian meta-analytic estimates were used to estimate the odds ratios (95% CI) for short-term mortality, major adverse cardiac events (MACE), and final TIMI 3 flow.
Results:
The AngioJet data included 11 studies and 1,018 patients. The PCI data included 81 studies and 24,076 patients. The AngioJet group included more patients with large thrombus burden, rescue PCI after failed thrombolytic therapy, and longer symptom duration compared to the PCI group. Despite the higher risk profile of AngioJet patients, the groups had similar odds of short-term mortality, 0.98 (0.53, 1.50), MACE, 1.25 (0.54, 2.40), and final TIMI 3 flow, 1.12 (0.70, 2.27).
Conclusion:
AngioJet thrombectomy results in clinical and angiographic outcomes that are similar to PCI in lower risk AMI patients. These observations suggest that AngioJet thrombectomy may reduce the additional risk associated with visible thrombus in the infarct-related lesion.
Related Concept Videos
01:30Acute Coronary Syndrome III: Diagnostic Studies
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:30Acute Coronary Syndrome I: Introduction
01:26Angina IV: Management